Nature Medicine - About the cover: Using CRISPR-Cas9–based genome editing technology, Sato and colleagues (featured on p 256 of this month's issue) introduce various combinations of mutations associated with human intestinal tumors
The next generation of CRISPR–Cas technologies and applications | Nature Reviews Molecular Cell Biology
Structural biology of CRISPR–Cas immunity and genome editing enzymes | Nature Reviews Microbiology
Correction of a pathogenic gene mutation in human embryos | Nature
Occurrence and Nature of Off-Target Modifications by CRISPR-Cas Genome Editing in Plants | ACS Agricultural Science & Technology
Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors | Nature Biotechnology
What's new in clinical CRISPR? | Nature Medicine
Efficient engineering of human and mouse primary cells using peptide-assisted genome editing | Nature Biotechnology
CRISPR screens for functional interrogation of immunity | Nature Reviews Immunology
The use of new CRISPR tools in cardiovascular research and medicine | Nature Reviews Cardiology
New CRISPR-based tool inserts large DNA sequences at desired sites in cells | MIT News | Massachusetts Institute of Technology
What rheumatologists need to know about CRISPR/Cas9 | Nature Reviews Rheumatology
In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer | Nature Immunology
CRISPR-Cas3 induces broad and unidirectional genome editing in human cells | Nature Communications
CRISPR–Cas9 genome editing induces a p53-mediated DNA damage response | Nature Medicine
The next generation of CRISPR–Cas technologies and applications | Nature Reviews Molecular Cell Biology
A first step toward in vivo gene editing in patients | Nature Medicine
The chemistry of Cas9 and its CRISPR colleagues | Nature Reviews Chemistry
Enhancing CRISPR/Cas gene editing through modulating cellular mechanical properties for cancer therapy | Nature Nanotechnology
The first human trial of CRISPR-based cell therapy clears safety concerns as new treatment for late-stage lung cancer | Signal Transduction and Targeted Therapy
Cornerstones of CRISPR–Cas in drug discovery and therapy | Nature Reviews Drug Discovery
Genome editing in animals with minimal PAM CRISPR-Cas9 enzymes | Nature Communications
Enhanced proofreading governs CRISPR–Cas9 targeting accuracy | Nature
